The Fed is expected to cut rates Wednesday, but it is unlikely to tell markets what they want to hear on future rate cuts.Market Insiderread more
Pelosi said Trump should not have tried to address China's trade practices in a way that opened Americans up to financial pain.Politicsread more
The fallout from two fatal crashes of Boeing 737 Max planes has ensnared the manufacturer's most-loyal customer: Southwest Airlines. The carrier has canceled thousands of...Airlinesread more
Brent crude oil jumped the most in history in the previous session after attacks on Saudi's oil industry disrupted the kingdom's production.Marketsread more
In the survey, conducted after the third in the Democratic Party's series of debate, the former vice president draws 31% compared to 25% for the Massachusetts senator. At 14%,...2020 Electionsread more
Stocks rose slightly on Tuesday, but gains were capped as the Federal Reserve kicked off a two-day monetary policy meeting.US Marketsread more
The U.S. Air Force's top general says he hasn't received direction to send additional bombers to the Middle East after what is believed to be Iranian attacks on Saudi Arabian...Defenseread more
Facebook has partnered with Ray-Ban maker Luxottica to develop augmented-reality glasses code-named 'Orion', people familiar with the matter told CNBC.Technologyread more
"I believe the path to 'health care for all' is a path following the lead of the Affordable Care Act," House Speaker Nancy Pelosi tells Jim Cramer.Health and Scienceread more
The pet food and product retailer posted net sales of $1.15 billion, topping estimates of $1.13 billion, according to a survey of analysts by Refinitiv.Retailread more
E-cigarette maker Juul Labs Inc.'s sales have been halted on two websites in China, just days after it launched in the world's biggest tobacco market.Biotech and Pharmaceuticalsread more
Sen. Elizabeth Warren, D-Mass., on Tuesday called on Scott Gottlieb, the former head of the Food and Drug Administration, to resign from Pfizer's board of directors, saying the appointment two months after leaving the agency "smacks of corruption."
"This kind of revolving door influence-peddling smacks of corruption, and makes the American people rightly cynical and distrustful about whether high-level Trump administration officials are working for them, or for their future corporate employers," Warren said in a July 1 letter to Gottlieb.
Pfizer last week announced Gottlieb would join its board of directors — a job that paid a minimum of $335,000 in stock and cash in 2018, according to a regulatory filing. Gottlieb stepped down from the agency that regulates the drugmaker in April.
"You should rectify your mistake and immediately resign from your position as a Pfizer board member," said Warren, who is running for the Democratic nomination for president in 2020. "Doing so would send a strong and necessary message to the American people about the importance of government ethics and the integrity of current and former federal officials."
Gottlieb in an interview with CNBC's "Squawk Box" earlier Tuesday defended his decision to join the board of a drug company he regulated just a few months ago.
"I worked with some large drugmakers before I came into the agency," Gottlieb said, adding that his new role at Pfizer is bigger than anything he did before the FDA. "I made no bones about the fact that I had expertise in life sciences and I made my living trying to promote innovation in this sector prior to coming to the agency."
Disclosure: Scott Gottlieb is a CNBC contributor.